Correlation Analysis
Meta Platforms, Inc. Class A Common Stock vs Alnylam Pharmaceuticals, Inc.
META vs ALNY
+0.693
Strong positive
When one moves up, the other tends to follow.
Meta Platforms, Inc. Class A Common Stock
↗META
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
Market cap 1.4T
Alnylam Pharmaceuticals, Inc.
↗ALNY
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.
Market cap 43.8B · 2,500 employees
Who Moves First
META leads ALNY by 6 days
META tends to move before ALNY.
Best correlation after shifting: +0.697 (13 shifts scanned)
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.285
10 periods · Return correlation when both series rose
Both Falling
-0.054
7 periods · Return correlation when both series fell
Diverging
-0.479
18 periods · Return correlation when series moved apart
R-Squared
48.0%
Share of variance in one series explained by the other.
Trend Agreement
56.9%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,106
Deep shared window — 1,106 usable pairs.
Significance
p < 0.001
95% CI: [0.661, 0.722]
Time Series
Rebased to 100
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,106 paired observations survived the daily window.
Raw input
1,107
1,253
Normalized
1,107
1,253
Prepared
1,107
1,253
Aligned
1,106
1,106
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
148
A: 1 / B: 147
Series A
Meta Platforms, Inc. Class A Common Stock
META
Market cap 1.4T
Stock · 1,107 raw → 1,107 prepared
Series B
Alnylam Pharmaceuticals, Inc.
ALNY
Market cap 43.8B · 2,500 employees
Stock · 1,253 raw → 1,253 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
7
Estimated crossover points between normalized spreads.
Slope
0.2467
Linear regression slope.
Intercept
144.9380
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
META
Meta Platforms, Inc. Class A Common Stock
Highest
+0.979
PCEC96
PCEC96 · 52 observations
Lowest
-0.939
United Parcel Service, Inc. Class B
UPS · 1,107 observations
ALNY
Alnylam Pharmaceuticals, Inc.
Highest
+0.842
JPMorgan Chase & Co.
JPM · 1,253 observations
Lowest
+0.460
Johnson & Johnson
JNJ · 1,253 observations
Saved 3 hours ago · ID: stock-meta-vs-stock-alny-daily-20260408-bmei9l